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Although whole-brain radiation therapy (WBRT) is the mainstay of treatment for brain
metastases (BMs), the concept of saving eloquent cortical lesions has been promoted.
If BMs from lung cancer are spatially biased to certain regions, this approach can be
justified more. We evaluated whether BMs from lung cancer show a preference for
certain brain regions and if their distribution pattern differs according to the histologic
subtype of the primary lung cancer. In this retrospective study, 562 BMs in 80 patients
were analyzed (107 BMs from small cell carcinoma, 432 from adenocarcinoma, and 23
from squamous cell carcinoma). Kernel density estimation was performed to investigate
whether BM spatial patterns differed among lung cancer subtypes. Further, we explored
more detailed subregions where BMs from adenocarcinomas occur frequently using
one-way analysis of variance. Finally, we divided our cohort into those with fewer
(≤10) and more (>10) BMs and evaluated whether this biased pattern was maintained
across limited and extensive stages. For small cell carcinoma, BMs were biased to the
cerebellum, but this did not reach statistical significance. For adenocarcinoma, BMs
were found more frequently near the distal middle cerebral artery (MCA) territory and
cerebellum than in other arterial territories (p < 0.01). The precentral and postcentral
gyri were the most significant subregions within the distal anterior cerebral artery (ACA)
and MCA territories (p < 0.01). Crus I and Lobule VI were significant regions within the
cerebellum (p < 0.01). Regardless of the number of BMs, the affinity to the distal MCA
territory and cerebellum was maintained. The present data confirm that BMs from lung
adenocarcinoma may preferentially involve the distal MCA territory and cerebellum.
Keywords: brain metastasis, lung cancer, adenocarcinoma, spatial distribution, arterial territory
INTRODUCTION
Brain metastases (BMs) are the most common intracranial neoplasms, outnumbering primary
malignant brain tumors by more than 10-fold (1, 2). The incidence of BMs is still increasing because
of the development of novel imaging techniques and improved survival rates (3). Lung cancer is
the most frequent source of BMs, and 30–50% of patients with lung cancer develop BMs during
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the course of the disease (4). Although advanced therapies have
improved the survival rates of lung cancer patients, BMs remain
an important cause of morbidities associated with progressive
neurologic deficits (5).
Whole-brain radiation therapy (WBRT) is currently the
treatment of choice for patients with multiple BMs not amenable
to surgery or radiosurgery. Although WBRT may prolong the
survival of patients, long-term complications of WBRT could
negatively impact their quality of life. Cognitive dysfunction
is seen in 50–90% of patients who survive for more than
6 months after irradiation (6–8). Moreover, radiation-induced
cognitive impairment occasionally progresses to dementia,
where patients experience enough progressive memory loss
to interfere with their daily lives (9). Hippocampal-sparing
WBRT has been recently introduced to prevent radiation-
induced cognitive deficits, which reduces the radiation dose
to the hippocampus while applying the usual higher dose to
other brain regions (10). In contrast, stereotactic radiosurgery
(SRS) has been explored and is increasingly utilized for
patients with limited BMs, as multiple Phase III randomized
trials have demonstrated comparable overall survival and
superior cognitive preservation and quality of life with SRS
alone compared to SRS with WBRT (11–13). Further, the
application of SRS has been expanded to patients with up to
10 BMs (14).
Interestingly, a few studies have reported the preferential
involvement of BMs in certain regions. Early studies
demonstrated the preferential involvement of BMs in anatomic
watershed areas, the gray-white matter junction, and the
cerebellum (15, 16). Tsukada et al. showed that breast cancer
has a predilection for posterior fossa metastases compared with
the cerebrum (17). Further, recent studies have suggested the
possibility of different distribution patterns of BMs according
to biological subtypes of primary cancer. BMs from lung
cancer with epidermal growth factor receptor (EGFR) L858R
mutations occurred more often in the caudate, cerebellum,
and temporal lobe than those with an exon 19 deletion of
EGFR (18). BMs from triple-negative breast cancers are evenly
distributed in the brain; meanwhile, BMs from HER2-positive
and luminal breast cancers occur primarily in the occipital
lobe and cerebellum (19). If lung cancer BMs have different
distribution patterns depending on histologic subtypes, radiation
planning should be adjusted. Additionally, if lung cancer BMs
show an affinity to certain brain regions, this knowledge could
be applied to radiation treatment planning. Reducing the dose
to the regions where BMs occur less frequently or low-dose
WBRT with tumor boost may prevent the development of
cognitive dysfunction, mood disorders, and motor impairment
in patients (20).
However, previous studies for lung cancer BM distribution
included patients with computed tomography (CT) or lower-
field-strength (1.5 T) magnetic resonance imaging (MRI), which
may miss small BMs (21). The sensitivity for the detection of
BMs can be improved remarkably by increasing the field strength
or gadolinium dose in MRI (22–24). They also performed lobar
analysis, which might not reflect the mechanism of BMs and it
might not be appropriate for finer radiation treatment planning.
In this study, we hypothesized that lung cancer BMs show
a preferential involvement in certain brain regions and that
their distribution pattern might differ according to histologic
subtypes of primary lung cancer. To test this hypothesis, we
generated probabilistic density functions of BMs and compared
BM frequencies in arterial territories according to each histologic
subtype. For adenocarcinoma, which is the most common
subtype to metastasize to the brain (25) and which was
associated with a significantly biased distribution of BMs in our
analysis, we further investigated the regions where BMs occurred
preferentially using a more detailed anatomical atlas.
MATERIALS AND METHODS
Participants
This retrospective study was approved by our institutional
review board, and the requirement to obtain informed patient
consent was waived. We retrospectively reviewed data from 136
lung cancer patients with BMs who underwent gadolinium-
enhanced brain MRI at our institution between October 2017
and December 2019. We excluded 56 patients for the following
reasons: (1) previous neurosurgery or brain radiation therapy
(n = 39), (2) presence of other malignant diseases (n = 8), (3)
motion or dental material artifact on MR images (n = 4), and
(4) a number of BMs per patient of more than 50 (n = 5) which
was considered an outlier. All patients had histopathological
diagnoses of lung cancer based on the results of bronchoscopic,
percutaneous needle-guided, or surgical biopsies. After exclusion,
80 patients with 562 BMs remained. Recursive partitioning
analysis (RPA) was used to classify patients into 1 of 3 categories:
Class I included patients with Karnofky performance status
(KPS) ≥70, age <65 years, controlled primary tumor, and no
extracranial metastases; Class III included patients with a KPS
<70; and Class II included all other patients (26). All data
were fully anonymized, and all experiments were carried out in
accordance with approved guidelines.
MRI and Preprocessing
Routine images for the evaluation of BMs were acquired
using a 3-T MR system (Vida, Siemens Healthineers; Erlangen,
Germany) with a 64-channel head/neck-matrix coil. T1-
weighted three-dimensional (3D) magnetization-prepared rapid
acquisition with gradient echo (MPRAGE) images were obtained.
After administering a 0.2 mmol/kg dose of gadobutrol (Gadovist,
Bayer Schering Pharma; Berlin, Germany), 3D turbo spin-
echo T1-weighted imaging (SPACE) was acquired. Sequence
parameters for 3D T1-weighted MPRAGE were as follows:
inversion time (TI) = 900 ms, echo time (TE) = 3 ms,
repetition time (TR) = 2,300 ms, flip angle = 9◦, slice
thickness = 1 mm, FOV = 256 mm, matrix = 256 × 256, slice
thickness = 1 mm, generalized autocalibrating partial parallel
acquisition (GRAPPA) = 2, and time of acquisition = 5 min
12 s; for 3D T1-weighted SPACE: TE = 33 ms, TR = 700 ms,
slice thickness = 0.8 mm, FOV = 230 mm, matrix = 288 × 288,
slice thickness = 0.8 mm, acceleration factor of compressed
sensing = 9, and time of acquisition = 3 min 44 s.
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MR images were processed using the FMRIB Software
Library1. For labeling BMs, 3D BM volumes were manually
segmented on the native 3D T1-weighted SPACE images by a
neuroradiologist. Binary labels of BMs were transformed into the
Montreal Neurological Institute (MNI) space by the following
process (Figure 1): 3D T1-weighted MPRAGE images were
co-registered to gadolinium-enhanced 3D T1-weighted SPACE
images using a rigid body transformation. The native 3D T1-
weighted MPRAGE images were transformed to the standard
MNI 152 T1-1-mm brain model using an affine transform matrix
(27). The estimated transform matrix was concatenated with a
1http://www.fmrib.ox.ac.uk/fsl
co-registration transform matrix, and the resulting matrix was
then applied to 3D T1-weighted SPACE images and binary BM
label images. Finally, for each BM, voxels for the centers of
gravity were localized, and all BMs were represented as single
voxels in 3D space.
Multivariate Non-parametric Kernel
Density Estimation
Multivariate non-parametric kernel density estimation was
performed to visualize the distribution of BM samples (28, 29).
Multivariate non-parametric kernel density estimation enables
better exploratory data analysis by reconstructing probabilistic
FIGURE 1 | Schematic illustration of the flow of image analysis.
TABLE 1 | Characteristics of lung cancer patients with brain metastases.
Characteristics Small cell carcinoma (N = 13) Adenocarcinoma (N = 58) Squamous cell carcinoma (N = 9) p-value
Age (years) 67.08 ± 9.32 65.78 ± 10.74 70.11 ± 8.46 0.61
Sex 0.05
Male 12 (92.3%) 21 (36.2%) 1 (11.1%)
Female 1 (7.7%) 37 (63.8%) 8 (88.9%)
Smoking history 0.01
Yes 9 (75%) 24 (43.6%) 8 (88.8%)
No 3 (25%) 31 (56.4%) 1 (11.2%)
RPA 0.01
1 0 (0%) 0 (0%) 1 (11.1%)
2 8 (72.7%) 49 (90.7%) 5 (55.5%)
3 3 (27.3%) 5 (9.3%) 3 (33.4%)
Number of BMs 107 432 23
Number of BMs per patient 8.23 ± 11.00 7.45 ± 7.41 2.56 ± 2.07 0.13
BM volume (mm3) 544.36 ± 2767.97 350.86 ± 1795.51 4097.30 ± 15793.24 0.04
RPA, recursive partitioning analysis, BM, brain metastasis.
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density functions using the sample data in a non-parametric












where Xi (i = 1, 2, . . . , N; N is the number of samples) is a
vector of size 1 × D containing multivariate sample and K
is a kernel which we assumed to be a multivariate Gaussian
variable with a diagonal bandwidth matrix  ∈ RD. The
Gaussian kernel is the most popular and is known for generating
smooth and realistic densities (32, 33). The bandwidth matrix
was estimated using a simple Silverman’s rule-of-thumb since





)1/(d+4) n−1/(d+4) σd (2)
where ωd (d = 1, 2, . . ., D) is an estimated diagonal bandwidth
and σd is the standard deviation of the data samples along the
d − th dimension.
FIGURE 2 | Probabilistic density function of brain metastases from three different histologic types of lung cancer: for small cell carcinoma, BMs were frequently
found in the cerebellum (A). For adenocarcinoma, BMs were clustered in the cerebellum, distal MCA, and ACA territories (B). For squamous cell carcinoma, BMs
were frequently observed in the right parietal lobe (C).
FIGURE 3 | Box plots of frequency of brain metastases in arterial territories for small cell carcinoma (A), adenocarcinoma (B), and squamous cell carcinoma (C).
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For each region of interest (ROI), a binary region mask of 5 mm
was dilated to consider the origin of BMs more accurately and
to standardize the chronological development of BMs (18). We
then counted the number of BM samples in each region of the
arterial-territory-based atlas to encode spatial patterns of BMs
for each subject (35, 36). One-way analysis of variance (ANOVA)
was performed to investigate whether the BM frequency differed
among arterial territories according to each lung cancer subtype.
Age, sex, and the area of each ROI were considered as covariates
in the general linear models for ANOVA. To explore the more
detailed anatomical hot spots of BMs from adenocarcinomas,
which were found to be associated with a significantly biased
pattern of BMs in a previous step, we applied the Harvard-Oxford
probabilistic atlas to the distal MCA and ACA territories and the
SUIT probabilistic cerebellum lobar atlas to the cerebellum (37,
38). Then, we compared BM frequencies between each subregion
using one-way ANOVA. The probabilistic cerebellum lobar atlas
was simplified by merging the left and right sides for each lobule,
and both probabilistic atlases were thresholded at 25% prior to
analyzing BM frequency. The significance level was set at p< 0.05
(39). To evaluate if biased patterns of BMs from adenocarcinoma
were maintained across limited and extensive stages, we divided
our cohort into those with a small number of BMs and those with
a large number of BMs and compared BM frequencies of arterial
territories in each group using one-way ANOVA.
RESULTS
Different Spatial Distributions of Lung
Cancer BMs in Different Histologic
Subtypes
A total of 80 patients with 562 metastases were included in
this study: 13 cases of small cell carcinoma with 107 BMs,
58 cases of adenocarcinoma with 432 BMs, and 9 cases of
squamous cell carcinoma with 23 BMs. Table 1 summarizes
patient characteristics. Sex, smoking history, RPA results, and
BM volume were significantly different among the three groups
(p < 0.05). Probabilistic density functions showed different
spatial distribution of BMs according to histologic subtypes of
primary lung cancer (Figure 2). For small cell cancer, BMs
were frequently found in the cerebellum. For adenocarcinoma,
BMs were clustered in the cerebellum, distal MCA, and ACA
territories. For squamous cell carcinoma, BMs were frequently
observed in the right parietal lobe.
Different Frequencies of Lung Cancer
BMs According to Arterial Territories in
Different Histologic Subtypes
Figure 3 and Table 2 show the results of one-way ANOVA for
BM frequency among arterial territories. To better understand
the spatial density of BMs, this model was adjusted for age,
sex, and the areas of arterial territories. In adenocarcinoma,
BMs were spatially biased (p < 0.01). According to post-hoc
analysis, there were significantly more BMs in the distal MCA
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FIGURE 4 | Comparison of the frequency of brain metastases from adenocarcinoma by subregions of the distal ACA and MCA territories. Yellow regions indicate a
low frequency of brain metastases (BMs) while black regions indicate a high BM frequency (A). Tukey’s HSD post-hoc pairwise test for comparison of BM frequency
between subregions in the distal ACA and MCA territories. All colored cells indicate a significant difference between two regions (p < 0.05). Darker colors indicate
greater differences in BMs between two regions (B). ACA; anterior cerebral artery; MCA, middle cerebral artery.
territory (1.79 ± 2.24) than in the proximal ACA (0.67 ± 1.14,
p < 0.01), middle ACA (0.66 ± 1.04, p < 0.01), proximal MCA
(0.86 ± 1.46, p = 0.04), proximal posterior cerebral artery (PCA)
(0.60 ± 0.91, p < 0.01), middle PCA (0.71 ± 0.97, p < 0.01),
or distal PCA territories (0.64 ± 1.09, p < 0.01, Supplementary
Table 1). There were significantly more BMs in the cerebellum
(1.62 ± 2.54) than in the proximal ACA (0.67 ± 1.14, p = 0.03),
middle ACA (0.66 ± 1.04, p = 0.02), proximal PCA (0.60 ± 0.91,
p = 0.01), or distal PCA territories (0.64 ± 1.09, p = 0.02). In
small cell carcinoma, there was a tendency to have more BMs in
the cerebellum compared with the other regions, but this was not
significant (p = 0.07). There were no significant spatial biases of
BMs in squamous cell carcinoma.
Comparison of BM Frequency by
Subregions of Distal ACA and Distal
MCA Territories in Adenocarcinoma
Figure 4 and Table 3 showed the results of one-way ANOVA
for BM frequency among subregions of the distal MCA and
ACA territories. The covariates were age, sex, and areas of
the subregions. In the distal ACA and MCA territories, BMs
were significantly biased in certain subregions (p < 0.01). BMs
were found most frequently in the precentral gyrus, followed
by the postcentral gyrus, middle frontal gyrus, and lateral
occipital cortex. According to post-hoc analysis, there were
significantly more BMs in the precentral gyrus (0.91 ± 1.51)
than in the superior temporal gyrus (0.22 ± 0.74, p < 0.01),
superior parietal lobule (0.34 ± 0.66, p = 0.02), anterior
supramarginal gyrus (0.10 ± 0.36, p < 0.01), posterior
supramarginal gyrus (0.12 ± 0.46, p < 0.01), angular gyrus
(0.10 ± 0.36, p < 0.01), or supplementary motor area
(0.09 ± 0.28, p < 0.01, Supplementary Table 2). There were
significantly more BMs in the postcentral gyrus (0.74 ± 1.14),
the middle frontal gyrus (0.71 ± 1.22), and the lateral occipital
cortex (0.67 ± 0.94) than in the anterior supramarginal gyrus
(0.10 ± 0.36), posterior supramarginal gyrus (0.12 ± 0.46),
angular gyrus (0.10 ± 0.36), and supplementary motor area
(0.09± 0.28, p < 0.05).
Comparison of BM Frequency by
Subregions of the Cerebellum in
Adenocarcinoma
One-way ANOVA showed that BMs were significantly biased to
certain subregions of the cerebellum (p < 0.01, Figure 5 and
Table 4). BMs were found most frequently in Crus I, followed
by Lobule VI and Crus II. According to post-hoc testing, there
were significantly more BMs in Crus I (0.71 ± 1.16) than in
Lobules I-IV (0.10 ± 0.44, p < 0.01), V (0.17 ± 0.53, p < 0.01),
VIIb (0.24 ± 0.43, p = 0.01), VIIIa (0.21 ± 0.41, p < 0.01),
VIIIIb (0.07 ± 0.25, p < 0.01), IX (0.05 ± 0.29, p < 0.01),
or X (0.03 ± 0.26, p < 0.01, Supplementary Table 3). There
were significantly more BMs in Lobule VI (0.62 ± 1.35) than in
Lobules I-IV (0.10 ± 0.44, p < 0.01), V (0.17 ± 0.53, p = 0.02),
VIIIIb (0.07 ± 0.25, p < 0.01), IX (0.05 ± 0.29, p < 0.01), or X
(0.03 ± 0.26, p < 0.01). There were significantly more BMs in
Crus II (0.48± 0.90) than in Lobule IX (0.05± 0.29, p = 0.03) or
X (0.03± 0.26, p = 0.02).
BM Distribution in Patients With Fewer
BMs (≤10) and Those With More BMs
(>10) From Adenocarcinoma
In 57 patients with 1–10 BMs from adenocarcinoma, BMs
were found most frequently in the cerebellum followed by the
distal MCA and middle MCA territories (Table 5). There were
significantly more BMs in these arterial territories (cerebellum:
0.74 ± 1.28, distal MCA: 0.72 ± 1.06, middle MCA: 0.54 ± 0.63)
than in other territories (p = 0.02, Supplementary Table 5). In
23 patients with more than 10 BMs from adenocarcinoma, BMs
were found most frequently in the distal MCA territory, followed
by the cerebellum and middle MCA territory. There were
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significantly more BMs in these arterial territories (distal MCA:
4.0 ± 2.41, cerebellum: 3.42 ± 3.41, middle MCA: 3.37 ± 1.81)
than in other territories (p < 0.01, Supplementary Table 6).
DISCUSSION
In this study, we tested the hypothesis that lung cancer BMs
may be spatially biased to certain brain regions and that their
distribution patterns differ between the lung cancer subtypes
of small cell carcinoma, adenocarcinoma, and squamous cell
carcinoma. Our results indicated that BMs of certain subtypes
may have different preferential areas of involvement in the brain.
Specifically, in adenocarcinoma, BMs were more frequently
found in the cerebellum and distal MCA territory than in other
arterial territories, and this tendency was maintained from the
limited to extensive stages of BMs. Furthermore, in the distal
ACA and MCA territories, the precentral gyrus, postcentral
gyrus, middle frontal gyrus, and lateral occipital cortex were hot
spots for BMs. In the cerebellum, Crus I, Lobule VI, and Crus
II were preferential subregions for BMs. Our study findings may
shed light on the mechanism by which lung cancer spreads to the
brain and may be utilized for tailoring radiation doses according
to lung cancer histology.
The preferential involvement of BMs in the cerebellum has
been reported in the previous literature. A previous CT-based
study demonstrated that the posterior fossa was involved in 50%
of patients when the primary tumor was pelvic or gastrointestinal,
but it was involved in only 10% of patients with other primary
tumors (15). However, recent MR-based studies showed an
increased probability of cerebellar metastases in lung and breast
cancer (40, 41). Our result also indicated that the cerebellum
is the preferential site for BMs of small cell carcinoma and
adenocarcinoma. The preferential involvement of the cerebellum
has been explained by the retrograde pathway of BMs. The
Batson venous plexus is a network of valveless veins that connect
the deep pelvic and thoracic veins to internal vertebral venous
plexuses. The cerebral dural sinuses are a direct extension of
the spinal epidural plexus. Thus, the pathway via the Batson
venous plexus to the cerebral dural sinuses can be an important
route for BMs (42). This mechanism may provide an explanation
for the occurrence of breast cancer and pelvic organ tumors,
which communicate with the Batson plexus. However, it may
not be applicable in lung cancer because lung cancer drains
through the pulmonary vein to the heart and spreads to distant
sites through direct arterial dissemination. Thus, the mechanism
for the preferential involvement of the cerebellum in small
cell carcinoma and adenocarcinoma is uncertain and further
study is necessary.
Interestingly, our results demonstrated that histologic
subtypes of lung cancer exhibit distinct distribution patterns
of BMs. BMs of squamous cell carcinoma did not show a
preferential involvement of the cerebellum. For small cell
carcinoma, BMs were frequently observed in the cerebellum.
For adenocarcinoma, BMs were frequently found not only
in the cerebellum but also in the distal MCA territory. The
differential distribution of BMs according to lung cancer subtype
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FIGURE 5 | Comparison of the frequency of brain metastases from adenocarcinoma by subregions of the cerebellum. Yellow regions indicate a low frequency of
brain metastases (BMs) while black regions indicate a high BM frequency (A). Tukey’s HSD post-hoc pairwise test for the comparison of BM frequency between
subregions of the cerebellum. All colored cells indicate a significant difference between two regions (p < 0.05). Darker colors indicate a greater difference in BMs
between two regions (B).
has been rarely studied. One study compared the frequency
of BMs by histologic subtypes and EGFR mutation status of
lung cancers. They found heterogeneity of BMs in small cell
carcinoma and adenocarcinoma, but not in squamous cell
carcinoma, which is in line with our study (18). It has been
revealed that small cell carcinoma and adenocarcinoma tend to
metastasize into the brain, whereas squamous cell carcinoma
prefers bones (43). Although the mechanism for the preferential
involvement of specific brain regions remains unknown, we
speculate That “seed and soil theory” may partially explain
it. The affinity of the tumor to the microenvironment plays a
role in extravasation and colonization of tumor cells at specific
sites (44). Recent studies support this notion at the molecular
level. Matrix metalloprotease-2 (MMP-2) and MMP-9 have
been reported to induce tumor cell invasion and metastasis
formation (45). Plasmin acts as a defense against metastatic
invasion. Neuroserpin and serpine B2 have been reported to
prevent plasmin generation (46). Also chemokine receptors
such as CXCR4 and CCR7 seem to play a critical role in
determining the metastatic destination (47). The expression
of these molecules may different depending on the subtypes
of lung cancer, but this hypothesis should be verified in
the future studies.
Our findings indicated that more BMs were found in the
distal arterial territories (ACA and MCA territories) than in the
proximal arterial territories. This finding supports the arterial
dissemination of BMs, in agreement with the rule that tumoral
emboli tend to pass along the arterial tree as far distally as their
size permits (48). However, the reason for the greater affinity of
BMs to the MCA territory than other arterial territories is not
known. We presume that it might be associated with the higher
blood flow rate of the MCA (21% of total cerebral flow rate)
compared with other territories (ACA: 12% of total cerebral flow
rate, PCA: 8% of total cerebral blood flow) (49).
Although WBRT was the mainstay of treatment for BMs,
its role has diminished over the last several decades. SRS is
preferred over WBRT for limited BMs because its efficacy
is non-inferior with greater preservation of neurocognitive
functioning and fewer serious adverse effects (13, 14). Even when
WBRT is applied, anatomic avoidance strategies are promoted
for cognitive preservation. Accumulating evidence has suggested
that hippocampal-sparing WBRT reduces neurocognitive
impairment (50, 51). Preserving the eloquent cortex is even more
justified when it is used for prophylactic cranial irradiation.
In this perspective, our results might be applied in planning
WBRT to selectively spare structures where BMs occur less
frequently. The precentral and postcentral gyri are significantly
associated with motor and sensory functions which might
severely affect patients’ quality of life. However, our subregion
analysis demonstrated that the precentral and postcentral
gyri were hot spots for BMs of adenocarcinoma within the
distal MCA and distal ACA territories. Thus, a usual higher
dose should be maintained in these regions. Furthermore, it
is notable that certain cerebellar subregions (Lobule IV and
Crus II) have more BMs than other regions. These regions
are commonly supplied by the distal superior cerebellar artery
(SCA). This may be due to a preference of BMs for the SCA
compared to the anterior inferior cerebellar artery or the
posterior cerebellar artery (52). Previous studies have revealed
that cerebellar lesions can cause motor deficits as well as cognitive
dysfunction. The anterior lobe is associated with motor skills
whereas the posterior lobe is associated with cognition (53,
54). Thus, radiation therapy based on detailed information
of BM distributions in the cerebellum may preserve motor or
cognitive function.
In our study, the BM distribution pattern for adenocarcinoma
did not differ between those with a small number of BMs and
those with a large number of BMs, which indicates that whatever
the mechanism of BM is, whether by arterial tumor emboli
or a retrograde pathway, the concentration in the distal MCA
territory and cerebellum is maintained from early to advanced
stages of BMs. Thus, our results may support the use of localized
radiation boosts to these regions.
This study had a limitation. Although there was a tendency
that BMs from small cell carcinoma were found more frequently
in the cerebellum than in other arterial territories, it was not
significant. We presume that this is probably due to the relatively
fewer number of BMs from small cell carcinoma than that of BMs





















TABLE 4 | Frequencies of brain metastases from adenocarcinoma by subregions of the cerebellum.
CB LB I-IV LB V LB VI Crus I Crus II LB VIIb LB VIIIa LB VIIIb LB IX LB X p-value
0.10 ± 0.44 0.17 ± 0.53 0.62 ± 1.35 0.71 ± 1.16 0.48 ± 0.90 0.24 ± 0.43 0.21 ± 0.41 0.07 ± 0.25 0.05 ± 0.29 0.03 ± 0.26 <0.01
This model was adjusted for age, sex, and the area of the arterial territory. Data shown are mean frequencies of brain metastases with standard deviations. CB, cerebellum; LB, lobule.
TABLE 5 | Arterial distribution patterns in patients with fewer BMs (≤10) and those with more BMs (>10).
Number of BMs ACA MCA PCA CB p-value
P M D P M D P M D
≤10 0.38 ± 0.84 0.28 ± 0.6 0.33 ± 0.61 0.28 ± 0.6 0.54 ± 0.63 0.72 ± 1.06 0.23 ± 0.42 0.26 ± 0.49 0.28 ± 0.64 0.74 ± 1.28 0.02*
>10 1.26 ± 1.41 1.42 ± 1.31 2.0 ± 1.41 2.05 ± 1.9 3.37 ± 1.81 4.0 ± 2.41 1.37 ± 1.13 1.63 ± 1.04 1.37 ± 1.42 3.42 ± 3.41 <0.01*
One-way analysis of variance was used to compare BM frequencies among arterial territories. This model was adjusted for age, sex, and the area of the arterial territory. Data shown are mean frequencies of brain
metastases with standard deviations. Asterisk (∗) indicates a p-value <0.05. BM, brain metastasis; ACA, anterior cerebral artery; MCA, middle cerebral artery; PCA, posterior cerebral artery; CB, cerebellum; P, proximal;
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from adenocarcinoma. Thus, future studies including more BMs
are necessary to validate this tendency.
CONCLUSION
In conclusion, our study demonstrated that BMs in lung
adenocarcinoma were biased to the distal MCA territory and
cerebellum. Within the distal ACA and MCA territories, the
precentral gyrus, postcentral gyrus, middle frontal gyrus, and
lateral occipital cortex were preferred subregions for BMs. Within
the cerebellum, Crus I, Lobule VI, and Crus II were hot spots. Our
results may not only enlighten the research on the mechanisms
underlying metastatic dissemination in the brain but can also
be used as a fundamental basis for developing tailored radiation
therapies for BMs.
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